HST Global - Dividend History | HSTC
Historical dividend payout and yield for HST Global (HSTC) since 1971. The current TTM dividend payout for HST Global (HSTC) as of December 31, 1969 is $0.00. The current dividend yield for HST Global as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.000B |
$0.000B |
|
HST GLOBAL, INC., formerly NT Holding Corp., is in the business of developing drugs to combat cancer. HSTI is a development-stage biopharmaceutical company that acquires and develops products for the treatment of cancer. The Company has focused on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer, and then developing those drug candidates for commercial use. The Company has entered into a letter of intent for the rights to one clinical stage drug candidate: Salicinium. Salicinium is an oral and parental active inhibitor. Clinical studies demonstrate that Salicinium alters malignant cell fermentation dynamics, blocks cell division (mitosis) and causes fermenting (cancer) cells' loss of ability to withstand the innate immune reactions.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
